Schizophrenia drug trial questioned
27 August 2008
 The US Food and Drug Administration (FDA) has requested more data on a schizophrenia treatment developed by Johnson & Johnson (J&J). J&J has been sent a "complete response" letter from the FDA, but the firm has not been ordered to carry out a second trial for the new drug.The company said the letter outlined further questions that needed to be addressed.During J&J's clinical trial of the intramuscular drug paliperidone palmitate, which is taken once a month, psychiatrist David Hough found the anti-psychotic reduced the likelihood of a relapse in patients suffering from schizophrenia to between ten and 15 per cent.J&J halted the drug trial early because of the clear benefits of the drug, which was tested against a placebo.Paliperidone palmitate uses patented NanoCrystal technology developed by Elan Pharma International.If J&J comply with the FDA's requests paliperidone palmitate could provide a new treatment for patients suffering from schizophrenia in the near future, according to webmd.com.  © Adfero Ltd
© 2008 Adfero Ltd. All rights reserved. Any views and opinions expressed in news articles are not those of Craegmoor Limited and its associated companies. News supplied by Adfero DirectNews.
Bookmark with:
What are these?
 Delicious
 Digg
 reddit
 Facebook
 StumbleUpon
Related stories
02/07/2009 Four pints a week increases hospital risk, research finds
New research has found that drinking four pints a week is enough to increase the risk of a person needing hospital and mental health treatment in their lifetime.
01/07/2009 Complicated pregnancy could increase risk of autism, suggests study
Complicated pregnancy could increase risk of autism, suggests study
01/07/2009 Preferred bidder announced for £100m mental health project.
An NHS service has said who it wants to take control of its £100 million mental health project.
30/06/2009 Bruno thanks nurses who helped him with mental health issues
Former world champion boxer and English darling Frank Bruno has been to thank the nurses who helped him recover from his much publicised mental health problems.
29/06/2009 CBT 'is an ineffective schizophrenia treatment'
Cognitive behavioural therapy (CBT) is an ineffective treatment for the mental health condition schizophrenia, new research claims.
|